ArticleScientific reports2020

Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial.

Takeshi Morimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.